Literature DB >> 23293890

Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.

Hui Sun1, Zhaoye Wang, Juan Sebastian Yakisich.   

Abstract

The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a key regulator of authophagy. Natural products show anticancer activity and often induce apoptosis or autophagy. The crosstalk between these two types of cell death makes autophagy an interesting target since drugs targeting this process not only can induce cell death by inducing autophagy but can also sensitize cells to apoptosis. Autophagy is also a protective mechanism associated with increased resistance to chemotherapy. In this review, we discuss natural products known to induce autophagy cell death in cancer cells via the PI3K/Akt/mTOR pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23293890     DOI: 10.2174/18715206113139990130

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  36 in total

1.  Inhibition of PI3K/Akt/mTOR signaling by natural products.

Authors:  Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

2.  Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway.

Authors:  Senthil Selvaraj; Yuyang Sun; Pramod Sukumaran; Brij B Singh
Journal:  Mol Carcinog       Date:  2015-04-27       Impact factor: 4.784

3.  Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G2/M cell cycle arrest.

Authors:  Jun-Xiao Zhang; Hong Wei-Tan; Chun-Yan Hu; Wei-Qiang Wang; Guang-Hua Chu; Li-Hui Wei; Liu Chen
Journal:  Exp Ther Med       Date:  2018-01-05       Impact factor: 2.447

4.  Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells.

Authors:  Gangadharan B Sajithlal; Hossein A Hamed; Nichola Cruickshanks; Laurence Booth; Seyedmehrad Tavallai; Jahangir Syed; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Mol Pharmacol       Date:  2013-07-22       Impact factor: 4.436

5.  Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo.

Authors:  Yi Rong Li; Shiming Li; Chi-Tang Ho; Ya-Han Chang; Kok-Tong Tan; Ting-Wen Chung; Bing-Yen Wang; Yu-Kuo Chen; Chi-Chen Lin
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

6.  FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway.

Authors:  Li Zhang; Handong Wang; Jianhong Zhu; Ke Ding; Jianguo Xu
Journal:  Tumour Biol       Date:  2014-07-30

7.  Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines.

Authors:  Qiuhong Zeng; Xiaofang Lin; Huadong Chen; Yixin Yan; Xianlong Wang
Journal:  Breast Cancer       Date:  2022-01-18       Impact factor: 3.307

8.  Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.

Authors:  Ksenia Lezhnina; Olga Kovalchuk; Alexander A Zhavoronkov; Mikhail B Korzinkin; Anastasia A Zabolotneva; Peter V Shegay; Dmitry G Sokov; Nurshat M Gaifullin; Igor G Rusakov; Alexander M Aliper; Sergey A Roumiantsev; Boris Y Alekseev; Nikolay M Borisov; Anton A Buzdin
Journal:  Oncotarget       Date:  2014-10-15

9.  Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism.

Authors:  Liang-Dong Li; He-Fen Sun; Xue-Xiao Liu; Shui-Ping Gao; Hong-Lin Jiang; Xin Hu; Wei Jin
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

10.  Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy.

Authors:  Hyun-Woo Lee; Kenny Seung Bin Jang; Hye Ji Choi; Ara Jo; Jae-Ho Cheong; Kyung-Hee Chun
Journal:  BMB Rep       Date:  2014-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.